AbCellera Biologics Inc. ABCL CA-BC — Accounts Receivable
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:GovernmentAssistanceAmountCumulative.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s ca-bc — accounts receivable.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s CA-BC — accounts receivable?
- AbCellera Biologics Inc. (ABCL) reported CA-BC — accounts receivable of $17.72M in Q1 2026.
- How has AbCellera Biologics Inc.'s CA-BC — accounts receivable changed year-over-year?
- AbCellera Biologics Inc.'s CA-BC — accounts receivable decreased by 17.4% year-over-year, from $21.45M to $17.72M.
- What does CA-BC — accounts receivable mean?
- Represents the total amount of money owed to the company by customers for services rendered or products delivered within the CA-BC geographic segment. This metric serves as a key indicator of the segment's short-term liquidity and the effectiveness of its credit and collection policies.